Pieris Corp (PVLA) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

Pieris Corp - PVLA emitenti grafik logotipi

GURU.Markets platformasidagi Pieris Pharmaceuticals (PVLA) joriy kotirovkalari grafigi, bunda ko'rsatkich 0.10 darajasida turibdi, ishlab chiqarishning ekologik toza yopiq sikllarga o'tishiga bog'liq. Immun dori vositalarini ishlab chiquvchi ushbu biznes hozirda qat'iy R&D xarajatlari limiti ostida daromadsiz restrukturizatsiyadan o'tmoqda. Shu bilan birga, molekulalarning muvaffaqiyati iqtisodiy sharoitlardan mustaqil bo'lgani sababli, aktivlar inqirozga chidamli bo'lib qolmoqda.

Pieris Pharma (PVLA): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 31.10.2026gacha

Pieris Pharmaceuticals (PVLA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi Pieris Pharma|PVLA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Pieris Pharmaceuticals, Inc.|PVLA - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Pieris Pharmaceuticals|PVLA - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati pieris.com|PVLA - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Pieris Pharmaceuticals|PVLA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati pieris.com|PVLA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Pieris Pharmaceuticals, Inc.|PVLA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Pieris Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi pieris.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
PVLA - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:Pieris Pharma - PVLA
Pieris Pharmaceuticals brend mahsuloti

Pieris Pharmaceuticals (PVLA) muvaffaqiyati klinik sinovlar va strategik ittifoqlarga bog'liq bo'lib, bu kompaniyani iqtisodiy sikllardan mustaqil qiladi. Uzoq muddatli qarzdorlikning kapitalga nisbati moliyaviy leverajni o'lchaydi, bunda aksiyalarning bozor qiymati maxrajni doimiy ravishda to'g'rilab turadi, bu esa investorlarga uzoq muddatli qarzdorlikning kapitalga nisbatini baholash orqali defolt xatarlari va biznesning o'sish potentsiali o'rtasidagi muvozanatni aniqlash imkonini beradi.

Muhim raqobatchilar

argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SEPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati SVRA|RIGL: Uzoq muddatli qarzning kapitalga nisbati|ANAB - Uzoq muddatli qarzdorlikning kapitalga nisbati|ATXS (Astria Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati enGene Holdings Inc ENGN|Uzoq muddatli qarzning o'z kapitaliga nisbati RAPT Therapeutics, Inc. (RAPT)|JBIO (aerovatetx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ACRS (Aclaris Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati kyvernatx.com (KYTX)|TLSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cabaletta Bio Inc. CABA|VTYX (Ventyx Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Theratechnologies, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Avalo Therapeutics, Inc|eledon.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati AGEN|CLYM (Climb Bio Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|Uzoq muddatli qarzning kapitalga nisbati aTyr Pharmaceuticals ATYR|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti IMA (ImageneBio Inc)|shattucklabs.com (STTK) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Equillium|CNTB (Connect Biopharma Holdings) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Immunic Inc|Uzoq muddatli qarzning kapitalga nisbati ATRA|Uzoq muddatli qarzning o'z kapitaliga nisbati inflarx.de IFRX|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Adicet Bio Inc. (ACET) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CELU: Uzoq muddatli qarzning o'z kapitaliga nisbati|INMB - Uzoq muddatli qarzning kapitalga nisbati|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KZR: Uzoq muddatli kreditlarning kapitalga nisbati|SABS (SAB Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Akari Therapeutics PLC (AKTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzning o'z kapitaliga nisbati q32bio.com QTTB|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|Uzoq muddatli qarzning kapitalga nisbati edesabiotech.com EDSA|IBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|CARM: Uzoq muddatli qarzning o'z kapitaliga nisbati|XTL Biopharmaceuticals, Ltd. (XTLB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BOLT - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Aptevo - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM (AIM ImmunoTech)|Uzoq muddatli qarzning o'z kapitaliga nisbati ADTX (aditxt.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XORTX Corp - Uzoq muddatli qarzning o'z kapitaliga nisbati|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|REVB - Uzoq muddatli qarzning kapitalga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati SCNI (Scinai Immunotherapeutics Ltd)|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ALLK|Uzoq muddatli qarzning kapitalga nisbati hookipapharma.com (HOOK)|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|TC BioPharm Ltd (TCBP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THRD: Uzoq muddatli qarzning kapitalga nisbati